Home › Companies › AMICUS THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and AMICUS THERAPEUTICS INC.’s Form 8-K, filed 2025-06-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore AMICUS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are AMICUS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Michael A. Kelly | 256,542,874 | -- | -- | 5,972,321 | 20,343,283 | Majority: yes |
| Elect Director: Margaret G. McGlynn | 253,119,576 | -- | -- | 9,395,619 | 20,343,283 | Majority: yes |
| Elect Director: Michael G. Raab | 159,986,932 | -- | -- | 102,528,263 | 20,343,283 | Majority: yes |
| Elect Director: Glenn P. Sblendorio | 255,741,822 | -- | -- | 6,773,373 | 20,343,283 | Majority: yes |
| Proposal 2: Approval of the 2025 Equity Incentive Plan. | 253,118,014 | 8,908,436 | 488,745 | -- | 20,343,283 | Majority: yes |
| Proposal 3: Ratification of Ernst & Young LLC as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025. | 277,786,618 | 5,006,701 | 65,159 | -- | -- | Majority: yes |
| Proposal 4: Approval, on an advisory basis, of the Company's executive compensation. | 255,789,585 | 6,169,769 | 555,841 | -- | 20,343,283 | Majority: yes |
Source: AMICUS THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-05 — read the filing on EDGAR.
Each item below shows how the 276 asset managers that disclosed a AMICUS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AMICUS THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Proposal 4: Approval, on an advisory basis, of the Company's executive compensation.”): 255,789,585 for, 6,169,769 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 269 asset managers below cast 99.1% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 50,664,311 | 16 | 0 | 0 | For |
| Wellington | 27,739,707 | 0 | 0 | 0 | For |
| BlackRock | 25,818,640 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 20,500,000 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 16,381,751 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13,676,359 | 0 | 0 | 0 | For |
| State Street | 12,190,166 | 12,067 | 0 | 0 | For |
| Redmile Group, LLC | 7,762,757 | 0 | 0 | 0 | For |
| American Century | 7,446,988 | 0 | 0 | 0 | For |
| Fidelity | 7,316,507 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,807,379 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 6,028,209 | 0 | 0 | 0 | For |
| Citadel | 5,337,109 | 0 | 0 | 0 | For |
| Charles Schwab | 5,036,419 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| Invesco | 4,499,188 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 4,034,737 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3,537,656 | 0 | 0 | 0 | For |
| Nuveen | 3,522,217 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| Northern Trust | 3,185,095 | 0 | 0 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| Janus Henderson | 3,113,021 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 2,829,626 | 0 | 0 | 0 | For |
Showing the 25 largest of 269 asset managers. See all 269 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Proposal 2: Approval of the 2025 Equity Incentive Plan.”): 253,118,014 for, 8,908,436 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 81 asset managers below cast 96% of the shares they voted on this item FOR (109,684,479 for, 4,106,709 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,825,672 | 0 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 0 | 3,547,888 | 0 | 0 | Against |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,232 | 162 | 0 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 518,700 | 351,212 | 0 | 0 | For |
| Equitable | 822,109 | 0 | 0 | 0 | For |
| T. Rowe Price | 784,270 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Proposal 3: Ratification of Ernst & Young LLC as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025.”): 277,786,618 for, 5,006,701 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 79 asset managers below cast 99.8% of the shares they voted on this item FOR (113,461,565 for, 133,212 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,823,190 | 2,482 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,232 | 162 | 0 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 822,109 | 0 | 0 | 0 | For |
| T. Rowe Price | 784,270 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Glenn P. Sblendorio”): 255,741,822 for, 6,773,373 withheld, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 78 asset managers below cast 100% of the shares they voted on this item FOR (111,924,883 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,825,672 | 0 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,232 | 0 | 162 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 465,580 | 0 | 356,529 | 0 | For |
| T. Rowe Price | 0 | 0 | 784,270 | 0 | Abstain |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Margaret G. McGlynn”): 253,119,576 for, 9,395,619 withheld, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 78 asset managers below cast 100% of the shares they voted on this item FOR (111,961,840 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,823,190 | 0 | 2,482 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,232 | 0 | 162 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 465,580 | 0 | 356,529 | 0 | For |
| T. Rowe Price | 0 | 0 | 784,270 | 0 | Abstain |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael A. Kelly”): 256,542,874 for, 5,972,321 withheld, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 78 asset managers below cast 100% of the shares they voted on this item FOR (112,059,825 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,825,672 | 0 | 0 | 0 | For |
| BlackRock | 14,260,470 | 0 | 0 | 0 | For |
| Fidelity | 6,929,698 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 3,325,394 | 0 | 0 | 0 | For |
| MFS | 3,133,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 2,518,083 | 0 | 0 | 0 | For |
| Invesco | 2,178,748 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 1,141,704 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 869,912 | 0 | 0 | 0 | For |
| Equitable | 465,580 | 0 | 356,529 | 0 | For |
| T. Rowe Price | 0 | 0 | 784,270 | 0 | Abstain |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 495,108 | 0 | 0 | 0 | For |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 431,284 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 385,828 | 0 | 0 | 0 | For |
| Northwestern Mutual | 327,828 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 6 wordings of this item as funds reported it.
61% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael G. Raab”): 159,986,932 for, 102,528,263 withheld, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 78 asset managers below cast 100% of the shares they voted on this item FOR (60,092,257 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 28,929,211 | 0 | 20,896,461 | 0 | For |
| BlackRock | 0 | 0 | 14,260,470 | 0 | Abstain |
| Fidelity | 6,531,731 | 0 | 397,967 | 0 | For |
| Delaware/Macquarie | 5,033,046 | 0 | 0 | 0 | For |
| American Century | 3,547,888 | 0 | 0 | 0 | For |
| TIAA | 3,490,010 | 0 | 0 | 0 | For |
| State Street | 11,549 | 0 | 3,313,845 | 0 | Abstain |
| MFS | 0 | 0 | 3,133,772 | 0 | Abstain |
| WILLIAM BLAIR FUNDS | 3,063,980 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 2,518,083 | 0 | Abstain |
| Invesco | 0 | 0 | 2,178,748 | 0 | Abstain |
| JPMorgan | 1,612,451 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,327,439 | 0 | 0 | 0 | For |
| Hartford | 0 | 0 | 1,141,704 | 0 | Abstain |
| PRIMECAP Odyssey Funds | 913,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 653,612 | 0 | 216,300 | 0 | For |
| Equitable | 0 | 0 | 822,109 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 784,270 | 0 | Abstain |
| PROFESSIONALLY MANAGED PORTFOLIOS | 711,565 | 0 | 0 | 0 | For |
| Goldman Sachs | 639,262 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 495,108 | 0 | Abstain |
| Allspring | 478,182 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 431,284 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 385,828 | 0 | Abstain |
| Northwestern Mutual | 0 | 0 | 327,828 | 0 | Abstain |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
98% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Proposal 4: Approval, on an advisory basis, of the Company's executive compensation.”): 255,789,585 for, 6,169,769 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 8 asset managers below cast 98% of the shares they voted on this item FOR (4,478,311 for, 106,045 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 3,974,220 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 320,200 | 0 | 0 | 0 | For |
| GuideStone | 177,227 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 105,445 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 4,213 | 0 | 0 | 0 | For |
| Vinva Investment Management Ltd | 2,403 | 0 | 0 | 0 | For |
| Sarasin & Partners LLP | 0 | 600 | 0 | 0 | Against |
| Colony Family Offices, LLC | 48 | 0 | 0 | 0 | For |
98% fund support · no official result
The 2 asset managers below cast 98% of the shares they voted on this item FOR (177,227 for, 4,213 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GuideStone | 177,227 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 4,213 | 0 | 0 | Against |
Ranked by the number of AMICUS THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 50,664,327 |
| 2 | Wellington | 27,739,707 |
| 3 | BlackRock | 25,818,640 |
| 4 | Avoro Capital Advisors LLC | 20,500,000 |
| 5 | PERCEPTIVE ADVISORS LLC | 16,381,751 |
| 6 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13,676,359 |
| 7 | State Street | 12,202,233 |
| 8 | Redmile Group, LLC | 7,762,757 |
| 9 | American Century | 7,446,988 |
| 10 | Fidelity | 7,316,507 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to AMICUS THERAPEUTICS INC. for the 2024-2025 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At AMICUS THERAPEUTICS INC.'s shareholder meeting held 2025-06-05, in the 2024-2025 proxy season, 276 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,035 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, the Company's executive compensation. — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AMICUS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-05.
AMICUS THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.